biostudies-literatureUnknown74(9)London NRFlight Attendant Medical Research InstituteNIAID NIH HHSNIEHS NIH HHSNHLBI NIH HHSFoundation for the National Institutes of HealthAmerican Rhinologic SocietyAllergy1780-1783https://www.ebi.ac.uk/biostudies/studies/S-EPMC6848889biostudies-literatureNrf2 activation via Keap1 deletion or sulforaphane treatment reduces Ova-induced sinonasal inflammation.PMC6848889R01 AI143731Clinical Investigator AwardR01 HL124099ES020859K23 ES020859R01 HL151107L30 ES022003Dobzanski AMendiola MHan AHChen MLondon NRSidhaye VBiswal STharakan AZaykaner MRamanathan MSussan TELane APfalseNrf2 activation via Keap1 deletion or sulforaphane treatment reduces Ova-induced sinonasal inflammation.2019-01-01T00:00:00Z2019 Sep2025-04-26T18:55:05.114Z2025-04-06T15:56:31.459ZS-EPMC68488893084322910.1111/all.13766